Biomedical Textiles Market by Fiber Type (Biodegradable, Non-biodegradable), Fabric Type (Woven, Non-woven), Application (Non-implantable, Surgical Sutures), and Region (North America, Europe, Asia Pacific, MEA, South America) - Global Forecast to 2022
[128 Pages Report] Biomedical textiles are fibrous structures designed for use in specific biological environments. The fibers used in these textiles should possess antimicrobial, fire-resistant, non-allergic, and non-carcinogenic properties. They are produced using weaving, non-weaving, and knitting technologies for surgical sutures, implantable, extracorporeal devices, and non-implantable applications.
The non-implantable application includes bandages, such as gauzes, adhesive, cohesive, and tubular and triangular. Surgical sutures can be made from both biodegradable and non-biodegradable fibers and are used for wound closure in surgeries. Implantable biomedical textiles are made of biodegradable fibers that can be used in specific biological environments and are biocompatible and biostable with cells and biological fluids. Biomedical textiles are also used in extracorporeal devices as mechanical organs that are used for blood purification.
The biomedical textiles market size was USD 11 billion in 2017 and is projected to reach USD 14.50 billion by 2022, at a CAGR of 5.7% during the forecast period. The rising number of surgeries, rapid growth in the aging population, and increased healthcare expenditure in the developing economies are expected to drive the biomedical textile market.
Non-Woven fabric to lead the biomedical textiles market between 2017 and 2022
The segment is projected to register the highest CAGR during the forecast period owing to increased consumption in the non-implantable applications. The increasing awareness and benefits of using this fabric in the healthcare industry are expected to drive its demand between 2017 and 2022.
Non-implantable to be the fastest-growing application of biomedical textiles between 2017 and 2022
The market in the non-implantable application is projected to register the highest CAGR between 2017 and 2022. An increasing number of accidents and surgeries is driving the biomedical textiles market in the non-implantable applications.
APAC to be the fastest-growing biomedical textiles market during the forecast period
The market in APAC is projected to register the highest CAGR during the forecast period. The biomedical textile manufacturing companies have ample growth opportunities in this region in comparison to the European and North American regions owing to the low cost of labor and raw materials. The consumption of biomedical textiles is high in this region due to the densely populated countries such as India and China, the rising income level of the population, and increasing expenditure on healthcare facilities.
China to register the highest CAGR in the biomedical textile market during the forecast period
Biomedical textiles are one of the top growth sectors for the technical textile market in China. The market in the surgical suture application is witnessing significant growth in China owing to an increase in the number of surgeries performed. According to the WHO data of 2012, 39,500,000 patients in China had undergone surgeries. Furthermore, the number of patients suffering from cardiovascular diseases is also increasing in the country, driving the demand for biomedical textiles in implantable products such as grafts and stents.
Market Dynamics
Driver: Growing need for advanced wound dressing material
Changing lifestyle, rising disposable income, and growing awareness about health and hygiene have increased the demand for biomedical textiles with antibacterial, anti-fungal, and easy healing properties. According to a survey conducted by Dow Microbial Control, a business unit of The Dow Chemical Company (US), more than 60% consumers demand advanced wound dressing materials having the ability to resist dust, mold, and parasites as well as bacterial, viral, and airborne infections. The survey also concluded that consumers prefer purchasing premium products to fulfill their requirements for wound dressing products with better performance.
Restraint: High R&D investments
Biomedical textiles are advanced materials that are specifically designed to resist various bacteria, fungi, fire, dirt, and water. The development of these fabrics involves extensive R&D to deliver specialized products that meet healthcare specifications. The R&D costs involved in the manufacturing of high-end fabrics are high as it involves labor, technological, and other related costs.
The production of raw materials such as polyester, cotton, polypropylene, polyurethane, vinyl, and other fibers involves complex processes that require heavy investments. The production of these materials also requires efficient machinery, the latest technology, and adequate supply. Raw materials used in antimicrobial biomedical textiles include various fibers and antimicrobial agents such as silver, copper, and quaternary ammonium, which are highly expensive. Moreover, players in the market need to monitor the production of high-quality textiles as it is a complex process. Thus, the R&D investments required in the manufacturing of these textiles are high, thereby restricting the growth of the market.
Opportunity: Development of smart biomedical textiles
Smart biomedical textiles are wearable materials produced by embedding tiny semiconductors and sensors into the fabrics. The smart biomedical textiles market is expected to grow at a rate of 20% per year. The use of these textiles in the patients clothing can help monitor heart rate, blood pressure, and pulse rate. They can also help monitor body temperature, respiratory rate, humidity, and pH level.
The European Commission is investing in R&D to develop smart biomedical textiles for various applications in West Sweden. Under this research, projects such as Context, Proetex, Sweet, Stella, Ofseth, Biotex, and Clevertex are being studied. The Context project is focused on the development of materials embedded with capacitive sensors that do not require direct body contact and can monitor a babys heart rate. Ofseth is working on optical fibers that could measure the oxygen content of blood and monitor patients in MRI chambers.
Challenge: Product marketing
The marketing of biomedical textiles is the biggest challenge for biomedical textiles manufacturers, as the majority of these products have to be marketed directly to hospitals. The hospitals have their own set of standards in terms of color, shape, and size of biomedical textiles, such as non-implantable disposables. In addition, the working capital cycle, especially in government hospitals is long, resulting in the delay of payments. Thus, the marketing of biomedical textiles remains one of the major challenges.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
20152022 |
|
Base year considered |
2016 |
|
Forecast period |
20172022 |
|
Forecast units |
USD million |
|
Segments covered |
Fiber Type, Fabric Type, Application, and Region |
|
Geographies covered |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, Australia & New Zealand, India, South Korea, and Rest of Asia Pacific), Middle East and Africa (South Africa, Saudi Arabia, UAE, Rest of MEA), and South America (Brazil, Argentina, Rest of South America) |
|
Companies covered |
Paul Hartmann (Germany), BSN Medical (Sweden), Royal DSM (Netherlands), Covidien (Ireland), Integra Life Sciences (US), Johnson & Johnson (US), Smith & Nephew (UK), Medline Industries (US), B. Braun Melsungen (Germany), and Cardinal Health (US) |
This research report categorizes the biomedical textiles market based on Fabric Type, Fiber Type, Application, and Region. It forecasts the revenue growth and analyzes trends in each of these submarkets.
By Fiber Type:
- Biodegradable
- Non-biodegradable
By Fabric Type:
- Non-Woven
- Woven
- Others
By Application:
- Non-Implantable
- Surgical Sutures
- Others
By Region:
- North America
- Europe
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- South America
Note: Other applications include implantable and extracorporeal devices. Other fabric types include braided, knitted, and hollow.
Key Market Players
Royal DSM (Netherlands), Medtronics (US), Cardinal Health (US), Integra Lifesciences Corporation (US), Medline (US)
Recent Developments
- In January 2018, Medtronic plc introduced the new SynchroMed(TM) II Intrathecal Drug Delivery system, an implantable pump that provides targeted drug delivery for chronic pain and severe spasticity. The SynchroMed II pump delivers medication directly to the fluid around the spinal cord.
- In January 2018, Ethicon launched SURGICEL POWDER ABSORBABLE HEMOSTAT, which is designed to help surgeons control disruptive bleeding more efficiently.
- In November 2017, DSM Biomedical developed a novel braiding technology by partnering with Meister & Cie AG. The technology uses UHMWPE fibers, Dyneema Purity fibers, for the design and construction of implantable medical devices. This platform technology offers medical device manufacturers freedom to design and the possibility for device miniaturization, thus enhancing the use of biomedical textiles in various applications.
- In October 2017, Smith & Nephew acquired Rotation Medical Inc. (US), the developer of a novel tissue regeneration technology for shoulder rotator cuff repair for USD 125 million. This acquisition will help Smith & Nephew to invest in innovative technologies that meet unmet clinical needs.
- In January 2017, Derma Sciences purchased the MEDIHONEY brand and related intellectual property from New Zealand-based Comvita Limiteds. This would help the company to expand its business in the APAC region.
Critical questions the report answers:
- What are the prime strategies followed by the market leaders/ key players in the market?
- Which market segment will witness an increase or decline in demand during the forecast period?
- Which segment or region will lead the market and why?
- What will be the revenue generating pockets for the key players in the market/industry?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.2.1 Market Size Estimation: Bottom-Up Approach
2.2.2 Market Size Estimation: Top-Down Approach
2.3 Data Triangulation
2.4 Assumptions
3 Executive Summary (Page No. - 25)
4 Premium Insights (Page No. - 30)
4.1 Significant Opportunities in the Biomedical Textile Market
4.2 Biomedical Textiles Market, By Application
4.3 Biomedical Textile Market, By Country and Region
4.4 US Biomedical Textiles Market, By Application
4.5 Biomedical Textile Market Attractiveness
5 Market Overview (Page No. - 33)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Number of Surgeries
5.2.1.2 Rapid Growth in Aging Population
5.2.1.3 High Quality of Biomedical Textiles
5.2.1.4 Growing Need for Advanced Wound Dressing Material
5.2.2 Restraints
5.2.2.1 High R&D Investments
5.2.3 Opportunities
5.2.3.1 Development of Smart Biomedical Textiles
5.2.3.2 Growing Demand From Emerging Markets
5.2.4 Challenges
5.2.4.1 Increasing Pricing Pressure on Market Players
5.2.4.2 Product Marketing
5.3 Porters Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Intensity of Competitive Rivalry
5.4 Industry Outlook
5.4.1 Contribution of the Healthcare Industry to GDP
6 Biomedical Textiles Market, By Fiber Type (Page No. - 42)
6.1 Introduction
6.2 Non-Biodegradable Fiber
6.2.1 Polypropylene and Polyethylene
6.2.2 Cotton
6.2.3 Viscose
6.2.4 Polyester
6.2.5 Polyamide
6.2.6 Others
6.2.6.1 Polyurethane
6.2.6.2 Polytetrafluoroethylene(Ptfe)
6.3 Biodegradable Fiber
6.3.1 Collagen
6.3.2 Chitin
6.3.3 Others
7 Biomedical Textile Market, By Fabric Type (Page No. - 47)
7.1 Introduction
7.2 Non-Woven Fabric
7.3 Woven Fabric
7.4 Others
7.4.1 Knitted & Braided Fabrics
7.4.2 Hollow Fabric
8 Biomedical Textiles Market, By Application (Page No. - 52)
8.1 Introduction
8.2 Non-Implantable
8.2.1 Bandages
8.3 Surgical Sutures
8.4 Others
8.4.1 Implantable
8.4.1.1 Soft Tissue Implants
8.4.1.2 Hard Tissue Implants
8.4.1.3 Dental Prosthesis
8.4.1.4 Vascular Devices
8.4.2 Extracorporeal Devices
9 Biomedical Textiles Market, By Region (Page No. - 66)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 APAC
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia & New Zeeland
9.4.5 South Korea
9.4.6 Singapore
9.4.7 Rest of APAC
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Rest of South America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Mea
10 Competitive Landscape (Page No. - 87)
10.1 Overview
10.2 Market Ranking of Key Players, 2016
10.3 Competitive Scenario
10.4 New Product Developments
10.5 Expansions
10.6 Acquisitions
10.7 Agreements & Partnerships
11 Company Profiles (Page No. - 93)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis & MnM View)*
11.1 Royal DSM N.V.
11.2 Medtronic PLC
11.3 Integra Lifesciences Corporation
11.4 Johnson & Johnson
11.5 Smith & Nephew PLC
11.6 Medline Industries, Inc.
11.7 B. Braun Melsungen AG
11.8 Cardinal Health, Inc.
11.9 Paul Hartmann AG
11.10 BSN Medical (A Part of Svenska Cellulosa Aktiebolaget Sca)
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis & MnM View Might Not Be Captured in Case of Unlisted Companies.
11.11 Other Companies
11.11.1 Atex Technologies
11.11.2 Elkem Silicones
11.11.3 Bally Ribbon Mills
11.11.4 US Biodesign
11.11.5 Nitto Denko Corporation
11.11.6 Kimberly-Clark Corporation
11.11.7 Mφlnlycke Health Care
11.11.8 3M Company
11.11.9 Ahlstrom-Munksjφ
11.11.10 Freudenberg & Co. Kommanditgesellschaft
11.11.11 Secant Group, LLC
11.11.12 Meister & Cie Ag
12 Appendix (Page No. - 121)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (62 Tables)
Table 1 Healthcare Expenditure of Countries in APAC
Table 2 Healthcare Expenditure of Countries in North America
Table 3 Healthcare Expenditure of Countries in Europe
Table 4 Healthcare Expenditure of Countries in South America
Table 5 Healthcare Expenditure of Countries in Mea
Table 6 Biomedical Textiles Market Size, By Fiber Type, 20152022 (USD Million)
Table 7 Non-Biodegradable Fiber Market Size, By Region, 20152022 (USD Million)
Table 8 Biodegradable Fiber Market Size, By Region, 20152022 (USD Million)
Table 9 Biomedical Textiles Market Size, By Fabric Type, 20152022 (USD Million)
Table 10 Non-Woven Fabric Market Size, By Region, 20152022 (USD Million)
Table 11 Woven Fabric Market Size, By Region, 20152022 (USD Million)
Table 12 Other Fabrics Market Size , By Region, 20152022 (USD Million)
Table 13 By Market Size, By Application, 20152022 (USD Million)
Table 14 By Market Size in Non-Implantable Application, By Region, 20152022 (USD Million)
Table 15 North America: By Market Size in Non-Implantable Application, By Country, 20152022 (USD Million)
Table 16 Europe: By Market Size in Non-Implantable Application, By Country, 20152022 (USD Million)
Table 17 APAC: By Market Size in Non-Implantable Applications, By Country, 20152022 (USD Million)
Table 18 South America: By Market Size in Non-Implantable Application, By Country, 20152022 (USD Million)
Table 19 MEA: By Market Size in Non-Implantable Application, By Country, 20152022 (USD Million)
Table 20 Biomedical Textiles Market Size in Surgical Sutures Application, By Region, 20152022 (USD Million)
Table 21 North America: By Market Size in Surgical Sutures Application, By Country, 20152022 (USD Million)
Table 22 Europe: By Market Size in Surgical Sutures Application, By Country, 20152022 (USD Million)
Table 23 APAC: By Market Size in Surgical Sutures Application, By Country, 20152022 (USD Million)
Table 24 South America: By Market Size in Surgical Sutures Application, By Country, 20152022 (USD Million)
Table 25 MEA: By Market Size in Surgical Sutures Application, By Country, 20152022 (USD Million)
Table 26 Biomedical Textiles Market Size in Other Applications, By Region, 20152022 (USD Million)
Table 27 North America: By Market Size in Other Applications, By Country, 20152022 (USD Million)
Table 28 Europe: By Market Size in Other Applications, By Country, 20152022 (USD Million)
Table 29 APAC: By Market Size in Other Applications, By Country, 20152022 (USD Million)
Table 30 South America: By Market Size in Other Application, By Country, 20152022 (USD Million)
Table 31 MEA: By Market Size in Other Applications, By Country, 20152022 (USD Million)
Table 32 Biomedical Textiles Market Size, By Region, 20152022 (USD Million)
Table 33 North America: By Market Size, By Fiber Type, 20152022 (USD Million)
Table 34 North America: By Market Size, By Application, 20152022 (USD Million)
Table 35 North America: By Market Size, By Country, 20152022 (USD Million)
Table 36 US: By Market Size, By Application, 20152022 (USD Million)
Table 37 Canada: By Market Size, By Application, 20152022 (USD Million)
Table 38 Mexico: By Market Size, By Application, 20152022 (USD Million)
Table 39 Europe: By Market Size, By Fiber Type, 20152022 (USD Million)
Table 40 Europe: By Market Size, By Application, 20152022 (USD Million)
Table 41 Europe: By Market Size, By Country, 20152022 (USD Million)
Table 42 Germany: By Market Size, By Application, 20152022 (USD Million)
Table 43 France: By Market Size, By Application, 20152022 (USD Million)
Table 44 UK: By Market Size, By Application, 20152022 (USD Million)
Table 45 Italy: By Market Size, By Application, 20152022 (USD Million)
Table 46 Spain: By Market Size, By Application, 20152022 (USD Million)
Table 47 APAC: By Market Size, By Fiber Type, 20152022 (USD Million)
Table 48 APAC: By Market Size, By Application, 20152022 (USD Million)
Table 49 APAC: By Market Size, By Country, 20152022 (USD Million)
Table 50 China: By Market Size, By Application, 20152022 (USD Million)
Table 51 Japan: By Market Size, By Application, 20152022 (USD Million)
Table 52 India: By Market Size, By Application, 20152022 (USD Million)
Table 53 South America: By Market Size, By Fiber Type, 20152022 (USD Million)
Table 54 South America: By Market Size, By Application, 20152022 (USD Million)
Table 55 South America: By Market Size, By Country, 20152022 (USD Million)
Table 56 MEA: By Market Size, By Fiber Type, 20152022 (USD Million)
Table 57 MEA: By Market Size, By Application, 20152022 (USD Million)
Table 58 MEA: By Market Size, By Country, 20152022 (USD Million)
Table 59 New Product Developments, 20162018
Table 60 Expansions, 2016-2018
Table 61 Acquisitions, 2016-2018
Table 62 Agreements & Partnerships, 2016-2018
List of Figures (35 Figures)
Figure 1 Biomedical Textiles By Market Segmentation
Figure 2 Biomedical Textiles By Market: Research Design
Figure 3 Biomedical Textiles By Market: Data Triangulation
Figure 4 Non-Woven Fabric to Lead the Biomedical Textiles Market Between 2017 and 2022
Figure 5 Non-Implantable to Be the Fastest-Growing Application of Biomedical Textiles Between 2017 and 2022
Figure 6 Non-Biodegradable Fiber to Lead the Biomedical Textile Market During the Forecast Period
Figure 7 China to Register the Highest CAGR in the Biomedical Textiles Market During the Forecast Period
Figure 8 APAC to Be the Fastest-Growing Biomedical Textile Market During the Forecast Period
Figure 9 The Biomedical Textiles Market to Register Significant CAGR Between 2017 and 2022
Figure 10 Non-Implantable to Be the Largest Application of Biomedical Textiles During the Forecast Period
Figure 11 US Accounted for the Largest Biomedical Textiles Market Share in 2016
Figure 12 Non-Implantable Application to Account for the Largest Share Between 2017 and 2022
Figure 13 China to Register the Highest CAGR During the Forecast Period
Figure 14 Overview of Factors Governing the Biomedical Textile Market
Figure 15 Porters Five Forces Analysis
Figure 16 Non-Biodegradable Fiber to Dominate the Biomedical Textiles Market Between 2017 and 2022
Figure 17 North America to Be the Largest Market for Non-Biodegradable Fiber Between 2017 and 2022
Figure 18 Non-Woven Fabric to Dominate the Biomedical Textile Market Between 2017 and 2022
Figure 19 APAC to Be the Fastest-Growing Non-Woven Fabric Market Between 2017 and 2022
Figure 20 North America to Be the Largest Market for Other Fabrics Between 2017 and 2022
Figure 21 Non-Implantable to Be the Largest Application of Biomedical Textiles Between 2017 and 2022
Figure 22 APAC to Be the Largest Biomedical Textiles Market in Surgical Sutures Application Between 2017 and 2022
Figure 23 North America to Be the Largest Biomedical Textile Market in Other Applications Between 2017 and 2022
Figure 24 US Leads the Biomedical Textiles Market
Figure 25 Germany to Register the Highest CAGR During the Forecast Period
Figure 26 China Dominates the Biomedical Textiles Market
Figure 27 Companies Adopted New Product Developments as the Key Growth Strategy Between 2016 and 2018
Figure 28 Royal DSM N.V.: Company Snapshot
Figure 29 Medtronic PLC: Company Snapshot
Figure 30 Integra Lifesciences Corporation: Company Snapshot
Figure 31 Johnson & Johnson: Company Snapshot
Figure 32 Smith & Nephew PLC: Company Snapshot
Figure 33 B. Braun Melsungen AG: Company Snapshot (2016)
Figure 34 Cardinal Health, Inc.: Company Snapshot
Figure 35 Paul Hartmann AG: Company Snapshot
Get in-depth analysis of the COVID-19 impact on the Biomedical Textiles Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Biomedical Textiles Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Biomedical Textiles Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Biomedical Textiles Market